FCGR2B rs1050501: What Your Genotype Means
The rs1050501 variant is a genetic change in the FCGR2B gene that affects how immune cells regulate antibody responses. Research has associated this variant with differences in total IgE levels and an increased susceptibility to allergic sensitization and atopy.
What each genotype means
Typical receptor function
This genotype represents the most common form of the FCGR2B gene, which encodes the inhibitory Fc gamma receptor IIb. Individuals with this genotype possess the standard receptor function that helps regulate immune responses and dampen B-cell activation.
This is the most common genotype across most global populations.
Intermediate receptor function
Carrying one copy of the C allele (also known as the 187Thr variant) may result in a partial reduction of the receptor's inhibitory signaling capacity. Research suggests this variant can be associated with altered immune regulation, though the clinical impact varies significantly between individuals.
This heterozygous genotype is found at varying frequencies, with higher prevalence observed in African and East Asian cohorts.
Reduced inhibitory signaling
This genotype results in the expression of a receptor variant that is less effective at providing inhibitory signals to B cells. Some studies have associated this genotype with elevated total IgE levels and an increased statistical risk for atopy, though it is not a definitive cause of allergic disease.
This genotype is less common than the T/T form, with a minor allele frequency for the C variant typically ranging between 10% and 20% globally.
What is rs1050501?
The rs1050501 variant is a single nucleotide polymorphism (SNP) located within the FCGR2B gene on chromosome 1q23.3. In genetic terms, this variant represents a change in the DNA sequence that results in a missense mutation, specifically substituting one amino acid for another in the resulting protein. This specific change is often referred to in scientific literature as the Thr187 variant, as it replaces the amino acid isoleucine with threonine at a critical position within the protein structure. Because this location is part of the receptor's transmembrane domain, the change can alter how the protein functions within the cell membrane. Scientists track this variant using its rsID, rs1050501, to study its distribution across different human populations and its potential impact on immune system behavior.
The Role of the FCGR2B Gene
The FCGR2B gene provides instructions for creating a protein known as Fc gamma receptor IIb (FcγRIIB). This receptor is unique because it is the only inhibitory Fc receptor found in humans. It is primarily expressed on the surface of various immune cells, including B cells, macrophages, and dendritic cells. Its main job is to act as a 'brake' on the immune system. When the receptor binds to immunoglobulin G (IgG) immune complexes, it triggers an inhibitory signal that prevents immune cells from becoming overactive. By dampening these signals, the receptor helps regulate antibody production and prevents the immune system from overreacting to harmless substances. When this receptor is impaired, the body may lose some of its ability to control inflammatory responses, which is why researchers study its function in the context of autoimmune conditions and allergic reactions.
Research and Associations
Scientific studies have investigated the link between rs1050501 and various immune-related conditions. Research indicates that the variant associated with the threonine substitution can impair the receptor's ability to send inhibitory signals. This functional defect has been linked in some studies to significantly elevated levels of total IgE, an antibody type central to allergic responses. Consequently, this variant has been identified as a potential risk factor for atopy and allergic sensitization. While the evidence for these associations is considered moderate, it is important to note that genetic associations are complex. Other factors, including environmental exposures and interactions with other genes, also play significant roles in the development of allergies. Furthermore, some research has explored this variant's role in autoimmune diseases like systemic lupus erythematosus, suggesting that the same genetic change might have different effects depending on the specific disease context and the population being studied.
Understanding Your Results
If you have received information about your rs1050501 genotype, it is important to interpret it within the context of current scientific understanding. Genetic variants are rarely the sole cause of a health condition; rather, they contribute to a person's overall risk profile. Having a specific genotype does not mean you will develop an allergy or any other condition, nor does it guarantee protection. This information is intended for educational purposes and should not be used to diagnose or treat any medical condition. If you are concerned about allergies, immune health, or how your genetics might influence your response to medications, you should discuss these topics with a qualified healthcare provider or a clinical geneticist. They can help you understand your results in the context of your personal health history and provide appropriate guidance for your specific situation.
How common is this variant?
The minor allele (C) frequency is approximately 0.10 to 0.20 across global populations. It is observed to be more frequent in African and East Asian cohorts compared to other groups.
Frequently asked questions
What does the rs1050501 variant do?
The rs1050501 variant causes a change in the FCGR2B protein, which is an inhibitory receptor on immune cells. This change can impair the receptor's ability to dampen immune signals, potentially leading to increased sensitivity in immune responses.
Is rs1050501 a cause of allergies?
No, it is not a direct cause. It is a genetic variant associated with an increased risk of atopy and higher IgE levels, but allergies are complex conditions influenced by many genetic and environmental factors.
Should I get tested for this variant?
Routine testing for this variant is not standard medical practice. Genetic testing for common variants is usually performed in research settings or as part of broader genomic studies rather than for individual clinical diagnosis.
Can I change my risk associated with this variant?
You cannot change your DNA sequence. However, understanding your health risks allows you to work with a doctor to manage environmental triggers and maintain overall immune health.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1050501?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29